Confluent saw its IBD SmartSelect Composite Rating jump to 96 Friday, up from 70 the day before.
The new score indicates the company is now outperforming 96% of all stocks in terms of the most important fundamental and technical stock-picking criteria.
Confluent is not currently near a proper buy point. See if the stock goes on to form a new base and offer a new buying opportunity.
Discover The 3 Keys To Successful Stock Investing
The stock earns an 81 EPS Rating, meaning its recent quarterly and annual earnings growth tops 81% of all stocks.
Its Accumulation/Distribution Rating of B shows moderate buying by institutional investors over the last 13 weeks.
The company reported a 400% earnings gain for Q3. Sales growth increased 25%, up from 24% in the prior report. That marks one quarter of increasing revenue growth.
Confluent earns the No. 2 rank among its peers in the Computer Software-Database industry group. Commvault Systems is the No. 1-ranked stock within the group.
